WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

  • WJAHR: MARCH ISSUE PUBLISHED

    MARCH 2026 Issue has been successfully launched on MARCH 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR March 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

METHOD DEVEOPMENT AND METHOD VALIDATION FOR SIMULTANEOUS EVALUATION OF ONDANSETRON AND RABEPRAZOLE SOLID DOSAGE FORM USING RP-HPLC TECHNIQUE

J. K. V. Sastry*, Dr. K. Atchuta Kumar, Mr. K. Charan Sai, Mrs. P. Prathyusha, Miss. N. Poojitha

ABSTRACT

Validation is an important concept in several industries, particularly those related to manufacturing, pharmaceuticals, and quality assurance. It entails a systematic approach to ensure that processes, systems, procedures, and equipment consistently execute their intended functions and provide dependable outcomes. Validation is critical for ensuring quality, adhering to regulatory standards, and reducing production and operational risks. The developed method was novel and simple for the simultaneous estimation of Ondansetron & Rabeprazole by RP-HPLC. The two peaks were well resolved at 275nm in isocratic mode at retention times 4.918 and 6.561 min for Ondansetron and Rabeprazole respectively at a run time of 15 min and flow rate 1.2ml/min with 250mm x 4.6mm, 5μm column & Ammonium acetate buffer: water: methanol (25:15:60) as mobile phase. % Assay values for Ondansetron and Rabeprazole were found to be 98.49% & 99.37% respectively. Linearity was obtained in the range of 16-48 ppm and linearity correlation coefficient was found to be 0.9995 & 0.9997 for Ondansetron and Rabeprazole respectively. This new approach was verified using ICH guidelines and found to be specific, sensitive, precise, accurate, and linear.

[Full Text Article] [Download Certificate]